The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2016

Filed:

Mar. 02, 2012
Applicants:

Bruce Allan Hay, Niskayuna, NY (US);

Daniel Eugene Meyer, Clifton Park, NY (US);

Brian Christopher Bales, Niskayuna, NY (US);

Michael Todd Luttrell, Niskayuna, NY (US);

Inventors:

Bruce Allan Hay, Niskayuna, NY (US);

Daniel Eugene Meyer, Clifton Park, NY (US);

Brian Christopher Bales, Niskayuna, NY (US);

Michael Todd Luttrell, Niskayuna, NY (US);

Assignee:

General Electric Company, Niskayuna, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/18 (2006.01); A61K 47/48 (2006.01); A61K 33/26 (2006.01); A61K 33/28 (2006.01); A61K 33/24 (2006.01); A61K 33/32 (2006.01); A61K 33/34 (2006.01);
U.S. Cl.
CPC ...
A61K 49/186 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01); A61K 47/48084 (2013.01); A61K 47/48215 (2013.01); A61K 47/48861 (2013.01); A61K 47/48884 (2013.01); A61K 49/1842 (2013.01); Y10T 428/2982 (2015.01);
Abstract

The present application discloses nanoparticles, particularly nanoparticles of superparamagnetic iron oxide, which find utility in iron therapy and diagnostic imaging such as magnetic resonance (MR). The disclosed nanoparticles have been treated with an α-hydroxyphosphonic acid conjugate containing polyethylene glycol as a hydrophilic moiety to render the nanoparticles sufficiently hydrophilic to find utility in diagnostic imaging. Among the modified hydrophilic nanoparticles disclosed are those in which the hydrophilic moieties of the modifying conjugate are polyethylene oxide-based polymers and have a molecular weight greater than 5,000 dalton and less than or equal to about 30,000 daltons. Surprisingly, these nanoparticles have a more rapid and complete processing in liver of retained nanoparticles when compared to similar nanoparticles in which the PEG-based hydrophilic moiety has a molecular weight less than 5,000.


Find Patent Forward Citations

Loading…